13F filer · CIK 2050709
Squadron Capital Management LLC
OAK BROOK, IL · filing since Q4 2025 · last filing Aug 14, 2026
Reported value
$322.2M
+$49.3M vs prior
Positions
43
New / sold out
24 / 18
Added / reduced
11 / 6
Turnover
35.7%
buys $128.7M · sells $106.3M
Top-10 weight
66.2%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | C4 THERAPEUTICS INC | +4,950,000 | +220.0% | +$23.1M |
| New | ENLIVEN THERAPEUTICS INC | +160,000 | – | +$8.1M |
| Added | INVENTIVA SA | +1,900,000 | +355.1% | +$7.2M |
| New | BIOAGE LABS INCCALL | +250,000 | – | +$6.1M |
| Added | RELAY THERAPEUTICS INC | +297,500 | +44.2% | +$5.6M |
| New | ADAGENE INC | +1,250,000 | – | +$5.3M |
| New | FORTE BIOSCIENCES INC | +225,000 | – | +$4.8M |
| New | REZOLUTE INCCALL | +900,000 | – | +$4.7M |
| Added | KODIAK SCIENCES INC | +120,000 | +31.6% | +$4.7M |
| New | INFLARX NV | +2,000,000 | – | +$4.5M |
25 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | KALVISTA PHARMACEUTICALS INC | -985,100 | -100.0% | $-19.8M |
| Sold out | ABIVAX SA | -130,000 | -100.0% | $-14.5M |
| Sold out | NEKTAR THERAPEUTICS | -125,000 | -100.0% | $-9.0M |
| Reduced | RELMADA THERAPEUTICS INC | -1,124,571 | -13.3% | $-7.8M |
| Sold out | SCYNEXIS INC | -7,608,695 | -100.0% | $-7.0M |
| Sold out | KALVISTA PHARMACEUTICALS INCCALL | -315,000 | -100.0% | $-6.3M |
| Reduced | ADLAI NORTYE LTD | -500,355 | -39.5% | $-5.8M |
| Sold out | EUPRAXIA PHARMACEUTICALS INC | -680,000 | -100.0% | $-4.9M |
| Sold out | GH RESEARCH PLC | -325,000 | -100.0% | $-4.6M |
| Sold out | KARYOPHARM THERAPEUTICS INCPUT | -750,000 | -100.0% | $-4.2M |
14 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | RELMADA THERAPEUTICS INCCOM | 7,350,000 | $50.9M | 15.78% |
| 2 | C4 THERAPEUTICS INCCOM STK | 7,200,000 | $33.6M | 10.43% |
| 3 | COGENT BIOSCIENCES INCCOM | 865,000 | $33.5M | 10.39% |
| 4 | KODIAK SCIENCES INCCOM | 500,000 | $19.5M | 6.05% |
| 5 | RELAY THERAPEUTICS INCCOM | 970,000 | $18.1M | 5.63% |
| 6 | ZENTALIS PHARMACEUTICALS INCCOM | 3,700,000 | $17.9M | 5.57% |
| 7 | EDGEWISE THERAPEUTICS INCCOM | 290,000 | $11.8M | 3.66% |
| 8 | MAZE THERAPEUTICS INCCOM | 335,000 | $10.0M | 3.10% |
| 9 | INVENTIVA SAADS | 2,435,000 | $9.2M | 2.86% |
| 10 | ADLAI NORTYE LTDSPONSORED ADS | 764,876 | $8.8M | 2.73% |
33 more rows. Subscribe for $29/month to see every row, download the data and use the API.